SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001558370-19-011670
Filing Date
2019-12-20
Accepted
2019-12-20 16:46:09
Documents
13
Period of Report
2019-12-17
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K bpmc-20190630x8k4c7b1a8.htm   iXBRL 8-K 37857
2 EX-10.1 ex-10d1.htm EX-10.1 45661
  Complete submission text file 0001558370-19-011670.txt   207971

Data Files

Seq Description Document Type Size
3 EX-101.SCH bpmc-20190630.xsd EX-101.SCH 3294
4 EX-101.LAB bpmc-20190630_lab.xml EX-101.LAB 15501
5 EX-101.PRE bpmc-20190630_pre.xml EX-101.PRE 10530
12 EXTRACTED XBRL INSTANCE DOCUMENT bpmc-20190630x8k4c7b1a8_htm.xml XML 4725
Mailing Address 45 SIDNEY STREET CAMBRIDGE MA 02139
Business Address 45 SIDNEY STREET CAMBRIDGE MA 02139 617-374-7580
Blueprint Medicines Corp (Filer) CIK: 0001597264 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37359 | Film No.: 191302138
SIC: 2834 Pharmaceutical Preparations